Whole-genome sequencing and single nucleotide polymorphisms in multidrug-resistant clinical isolates of Mycobacterium tuberculosis from the Philippines

Author:

Roa Marylette B.ORCID,Tablizo Francis A.,Morado El King D.,Cunanan Lovette F.,Uy Iris Diana C.,Ng Kamela Charmaine S.ORCID,Manalastas-Cantos Karen G.,Reyes Joeriggo M.,Ganchua Sharie Keanne C.,Ang Concepcion F.,Kato-Maeda Midori,Cattamanchi Adithya,Karaoz Ulas,Destura Raul V.,Lluisma Arturo O.

Funder

Emerging Science and Technology Grant from the University of the Philippines

Publisher

Elsevier BV

Subject

Microbiology (medical),Immunology,Immunology and Allergy,Microbiology

Reference38 articles.

1. Global tuberculosis report 2017;World Health Organization (WHO),2017

2. Low prevalence of fluoroquinolone resistance among patients with tuberculosis in the Philippines: results of a national survey;Lim;Eur Respir J,2018

3. Stop TB Partnership. High burden countries. Geneva, Switzerland: United Nations Office for Project Services (UNOPS). http://www.stoptb.org/countries/tbdata.asp.

4. Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis;Caminero;Lancet Infect Dis,2010

5. First tuberculosis cases in Italy resistant to all tested drugs;Migliori;Euro Surveill,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3